Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Peter Podhaisky

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|April 24, 2024
Digital Health Technology (DHT) in European Clinical Trials, How to Improve the Status-Quo of the Regulatory Landscape?Hans-Peter Podhaisky
Journal of Dermatological Science|March 28, 2002
Is the photoprotective effect of vitamin E based on its antioxidative capacity?Hans-Peter Podhaisky, Wolfgang Wohlrab
Therapeutic Innovation & Regulatory Science|May 17, 2023
Digital Tools-Regulatory Considerations for Application in Clinical TrialsLian Gelis, Isabelle Stoeckert, Hans-Peter Podhaisky
Therapeutic Innovation & Regulatory Science|July 13, 2026
How Digital Health Technologies have been Used to Support Regulatory Drug ApprovalAgathe Thierry, Antoine Manson, Hans-Peter Podhaisky
Acta Dermato-Venereologica|November 15, 2002
Relevance of reactive oxygen species in the induction of 8-oxo-2'-deoxyguanosine in HaCaT keratinocytesStephan Riemschneider, Hans-Peter Podhaisky, Thomas Klapperstück, et al.
Pharmacological Research|March 9, 2002
Evidence for a role of nitric oxide in the mediation of antiproliferative UVA effects in keratinocytesHans-Peter Podhaisky, Thomas Klapperstück, Stephan Riemschneider, et al.
Therapeutic Innovation & Regulatory Science|January 28, 2025
Impact of Rule 11 on the European Medical Software Landscape: Analysis of EUDAMED and Further Databases Three Years After MDR ImplementationArndt A Schmitz, Miriam Font-Nieves, Toumani Doucouré, et al.
The Journal of Pharmacy and Pharmacology|November 11, 2003
Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of actionHagen Trommer, Manuela Plätzer, Klaus Raith, et al.
JMIR Medical Informatics|July 13, 2021
Digital Medical Device Companion (MyIUS) for New Users of Intrauterine Systems: App Development StudyToeresin Karakoyun, Hans-Peter Podhaisky, Ann-Kathrin Frenz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|April 24, 2024
Digital Health Technology (DHT) in European Clinical Trials, How to Improve the Status-Quo of the Regulatory Landscape?Hans-Peter Podhaisky
Journal of Dermatological Science|March 28, 2002
Is the photoprotective effect of vitamin E based on its antioxidative capacity?Hans-Peter Podhaisky, Wolfgang Wohlrab
Therapeutic Innovation & Regulatory Science|May 17, 2023
Digital Tools-Regulatory Considerations for Application in Clinical TrialsLian Gelis, Isabelle Stoeckert, Hans-Peter Podhaisky
Therapeutic Innovation & Regulatory Science|July 13, 2026
How Digital Health Technologies have been Used to Support Regulatory Drug ApprovalAgathe Thierry, Antoine Manson, Hans-Peter Podhaisky
Acta Dermato-Venereologica|November 15, 2002
Relevance of reactive oxygen species in the induction of 8-oxo-2'-deoxyguanosine in HaCaT keratinocytesStephan Riemschneider, Hans-Peter Podhaisky, Thomas Klapperstück, et al.
Pharmacological Research|March 9, 2002
Evidence for a role of nitric oxide in the mediation of antiproliferative UVA effects in keratinocytesHans-Peter Podhaisky, Thomas Klapperstück, Stephan Riemschneider, et al.
Therapeutic Innovation & Regulatory Science|January 28, 2025
Impact of Rule 11 on the European Medical Software Landscape: Analysis of EUDAMED and Further Databases Three Years After MDR ImplementationArndt A Schmitz, Miriam Font-Nieves, Toumani Doucouré, et al.
The Journal of Pharmacy and Pharmacology|November 11, 2003
Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of actionHagen Trommer, Manuela Plätzer, Klaus Raith, et al.
JMIR Medical Informatics|July 13, 2021
Digital Medical Device Companion (MyIUS) for New Users of Intrauterine Systems: App Development StudyToeresin Karakoyun, Hans-Peter Podhaisky, Ann-Kathrin Frenz, et al.
Pageof 1